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ABSTRACT
Cre is widely used for DNA tailoring and, in
combination with recombineering techniques,
to modify BAC/PAC sequences for generating
transgenic animals. However, mammalian genomes
contain recombinase recognition sites (cryptic loxP
sites) that can promote illegitimate DNA recombina-
tion and damage when cells express the Cre
recombinase gene. We have created a new bioinfor-
matic tool, FuzznucComparator, which searches for
cryptic loxP sites and we have applied it to the
analysis of the whole mouse genome. We found that
cryptic loxP sites occur frequently and are homo-
geneously distributed in the genome. Given the
mammalian nature of BAC/PAC genomic inserts, we
hypothesised that the presence of cryptic loxP sites
may affect the ability to grow and modify BAC and
PAC clones in E. coli expressing Cre recombinase.
We have observed a defect in bacterial growth when
some BACs and PACs were transformed into EL350,
a DH10B-derived bacterial strain that expresses Cre
recombinase under the control of an arabinose-
inducible promoter. In this study, we have demon-
strated that Cre recombinase expression is leaky in
un-induced EL350 cells and that some BAC/PAC
sequences contain cryptic loxP sites, which are
active and mediate the introduction of single-strand
nicks in BAC/PAC genomic inserts.
INTRODUCTION
BAC and PAC clones have become the preferred tool for
generating transgenic animals, since they accommodate
large genomic DNA fragments, are well characterized, stable
and easy to propagate and purify. In recent years, eﬃcient
and reliable methods have been developed to modify their
sequence in E. coli. These techniques are generally termed
recombineering (homologous recombination-mediated
genetic engineering) and they are based on homologous
recombination between a linear double-stranded DNA
cassette or synthetic oligonucleotides and a circular DNA
molecule (plasmid, BACs or PACs) (1,2). A variety of
methods and strains have been described for homologous
recombination, but the most widely used methods derive
the homologous recombination machinery from the
bacteriophage -encoded Red system (3). The DY380
strain of E. coli is derived from DH10B and encodes
a defective -prophage, in which the recombina-
tion apparatus is expressed under the control of the
temperature-sensitive  repressor (cI857) (3,4). Two
further strains have been derived from DY380 in which
the tetracycline resistance gene, (encoded on the bacterial
genome) is substituted by either Flp (strain EL250) or
Cre (strain EL350) genes (5). The Flp or Cre genes are
expressed under the control of the arabinose-inducible
AraC-PBAD promoter to allow further manipulation of
introduced BAC/PACs. Cre DNA recombinase catalyses
the recombination between two 34-bp loxP elements. The
outcome (excision or inversion) depends on the relative
orientation of the 2 loxP elements (6). The loxP element
contains a core spacer sequence of 8-bp ﬂanked by two
palindromic sequences each of 13-bp to which Cre binds
(7). Up to 5 mismatches from the consensus in each of the
two palindromic sequences can be tolerated by Cre,
without signiﬁcantly reducing DNA binding (8,9). The
core sequence is the cleavage site; its asymmetry deﬁnes
the direction of the loxP site and homology in this region
between two loxP sites is required for eﬃcient recombina-
tion (10). When recombination occurs between a mutant
loxP site, which bears a deletion in the spacer region,
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and a wild-type loxP site, the introduction of single- and
double-strand breaks in the DNA may occur (11). On a
statistical basis, the 34-bp consensus loxP site is not
expected to be present in mammalian genomes, but the
presence of functional recombinase recognition sites, that
diverge signiﬁcantly from the native loxP site, has been
identiﬁed in both the human and mouse genomes (12).
These cryptic (or pseudo) loxP sites, can support
Cre-mediated recombination at high eﬃciency when
cryptic loxP sites with the same spacer region are involved
in the recombination (12). Studies have shown that Cre
expression in mammalian cells causes recombination
events between cryptic loxP sites resulting in gross
chromosomal rearrangements in spermatids (13) and, in
cultured mammalian cells, growth inhibition accompanied
by DNA damage (14). Furthermore, recombination can
occur even when the spacer regions display a relatively
high level of non-homology (15). Moreover, it is generally
acknowledged that some large DNAs grow slowly in
Cre-containing E. coli and it has been reported that
modiﬁed strains of E. coli are not ideal for receiving
PACs and BACs and some BAC clones cannot be
transformed into such strains for reasons that are not
fully understood (16).
Our hypothesis is that cryptic loxP sites, encoded in the
mammalian genomic DNA insert, may act as substrates
for Cre recombinase, expression of which may be leaky
in some bacterial strains.
Here, we describe the use of a bioinformatics tool to
identify such cryptic sites and experiments to test these
predictions carried out on BAC/PACs.
MATERIAL AND METHODS
In silico identification of cryptic loxP sites
To automate the identiﬁcation of cryptic loxP sites
within a given DNA sequence a bioinformatics workﬂow
was created using Taverna [TAVERNA] (17). Taverna
provides a workbench application that enables the
construction and enactment of workﬂows within a
graphical environment. A schematic representation of
the workﬂow is illustrated in Figure 1. This workﬂow
takes a DNA sequence and searches for matches to three
diﬀerent patterns using Fuzznuc, which is freely available
as part of the European Molecular Biology Open Software
Suite (EMBOSS) [EMBOSS] (18) and is accessed via a
Soaplab [SOAPLAB] web service (19).
Pattern 1 is described by the sequence ATAACTTCGT
ATA (N)8 TATACGAAGTTAT (12) and it selects
for high homology in the 13-bp palindromic regions
of the wild-type loxP. This pattern is augmented by
a mismatch parameter that allows up to 10 mismatches
to be tolerated (8,9). Pattern 2 is described by the sequence
ATNAC(N)2CNTATA (N)8 TATANG(N)2GTNAT.
It selects for conservation of those base pairs in the loxP
site believed to be contact points for the Cre enzyme
(underlined bases in the sequence ATAACTTCGTATA
ATGTATGC TATACGAAGTTAT). This pattern
is augmented by a mismatch parameter that allows up to
5 mismatches to be tolerated. We hypothesized that
the mismatches allowed in this search could be tolerated
by the Cre recombinase. Pattern 3 is described by
the sequence (N)9TATA (N)8 TATA(N)9. It ensures that
the TATA motif surrounding the core 8-bp spacer region
is present. This pattern is augmented by a mismatch
parameter that ensures no mismatches are tolerated.
The fulﬁlment of these three criteria deﬁnes a primary
cryptic loxP site and provides a wider classiﬁcation then
previously proposed (12).
A web service called FuzznucComparator was
developed that compares the output from two Fuzznuc
processes and outputs only those sequences present in
both. When the result of the comparison contains
more than one sequence, the FuzznucComparator tool
performs 2 pairwise alignments of the core 8-bp spacer
regions. The ﬁrst alignment is calculated using the
sequences in their given orientation. The second comple-
ments one sequence prior to making the alignment.
The output ﬁle format consists of the result of the
pairwise comparison (if any) followed by those sequences
present in both input ﬁles in fuzznuc’s seqtable format.
To isolate those sequences that match all three
patterns two comparisons are required. First, a
FuzznucComparator process is used to isolate those
sequences that match patterns 1 and 2. A ﬁleDivider
process splits the output content and outputs only the
fuzznuc seqtable section. Second, a FuzznucComparator
process compares the output from the ﬁleDivider process
Pattern 1
Mismatch 1
Fuzznuc comparator 1
DNA sequence File path creator
Fuzznuc 1
Pattern 2
Mismatch 2
Pattern 3
Mismatch 3
Fuzznuc 2
Fuzznuc 3
File divider Fuzznuc comparator 2
Write text file
Figure 1. Schematic representation of the workﬂow created to automate the identiﬁcation of cryptic loxP sites.
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with those sequences that match pattern 3. The ﬁnal
step in the workﬂow is to write those sequences that match
all three patterns to ﬁle. The Scuﬂ workﬂow can
be downloaded from http://www.bioinf.mvm.ed.ac.uk/
projects/workﬂows/loxp. This workﬂow can be opened
and enacted within the Taverna workbench. A web page
interface to this workﬂow is also freely available at: http://
wilkie226.dmed.ed.ac.uk:8080/loxpFinder.
The default mismatch values enable discovery of
primary cryptic loxP sites. The Taverna workbench
and the web page interface enable users to edit the
workﬂow and thus change the number of mismatches
tolerated for each pattern. By relaxing the number of
allowed mismatches the workﬂow can ﬁnd secondary
cryptic loxP sites. Additional information regarding
how to use these resources is available in the online
manual.
Plasmid, BAC/PAC vectors, E. coli strains and growth
conditions
pROSA26/Tet is a pBluescript-modiﬁed plasmid contain-
ing a tetracycline resistance gene sub-cloned between
two loxP consensus sequences (pROSA26 unpublished,
personal gift from Yuri Kotelevtsev, University of
Edinburgh. Original source Igor Samokhvalov,
RIKEN Center for Developmental Biology, Kobe
Japan). This plasmid contains no AraC-PBAD promoter
elements.
PAC111L11 (20) (kindly provided by Craig A. Jones,
Buﬀalo, New York) maps on human chromosome 1 and
spans the Ren gene locus. The vector backbone
(pCYPAC2) contains a single consensus loxP site
and encodes kanamycin resistance. BACN10 was isolated
by the screening of a mouse genomic library (129/Ola
mouse strain) (Invitrogen Corporation, Formally
Research Genetics) using a renin gene probe. It maps
on mouse chromosome 1 and spans the Ren1c and Ren1d
gene locus. The vector backbone (pBeloBAC11) contains
a single loxP site and encodes chloramphenicol resistance.
ASBAC (kindly provided by Keith Parker Dallas, Texas)
also comes from a pBeloBAC11 library, and maps to
chromosome 15, spanning the cyp11b1 and cyp11b2 genes.
[BAC ends coordinates refer to RP23-23009 clone
sequence T7: 205723 bp, SP6: 82689 bp]. The DY380,
EL250 and EL350 strains of E. coli have been described
(3), and were kindly provided by Neal Copeland (Mouse
Cancer Genetics Program, National Cancer Institute-
Frederik).
EL350 and EL250 diﬀer from DY380 in that they
encode the Cre and Flp recombinase genes respectively
under the control of AraC-PBAD promoter and they are
not tetracycline resistant (5).
One hundred nanograms of PAC or BAC DNA were
transformed into EL350 and DY380 bacterial strains
by electroporation (Easyjet Plus, Equibio; 1.75 kV,
200 ohms, 2 mF). Following selection on kanamycin/
chloramphenicol plates, a 106 dilution of cells was
plated on LB agar plates containing either 0.2% arabinose
or 0.2% glucose and incubated overnight at 328C.
In vivo assay forCre activity in EL350
EL350 cells were transformed with 40 ng of pROSA26/
TET plasmid DNA by electroporation and plated on LB
agar containing 50 mg/ml ampicillin or 25 mg/ml tetra-
cycline or both antibiotics. After overnight growth at 328C,
colonies were counted and the ratio of tetracycline-
resistant colonies to ampicillin-resistant colonies calcu-
lated as a measure of the Cre gene expression in EL350 in
the un-induced state. This measure was then compared to
the Cre activity after induction of the PBAD-promoter with
0.1% arabinose, according to a protocol adapted from
Lee et al. (2001) (5) which is available at http://
recombineering.ncifcrf.gov/Protocol.asp. Two cell dilu-
tions (104 and 106) were plated on Amp, Amp/Tet and
Tet plates.
In vitro assay for BAC/PACDNA nicking
One microgram of BAC/PAC DNA extracted from
DY380 cells was incubated with 1 or 2 ml of Cre enzyme
(1000 U/ml, New England Biolabs) overnight. After the
incubation, each reaction was phenol-chloroform
extracted and ethanol precipitated. An aliquot of DNA
was then digested with EcoRV or HindIII restriction
enzymes (Promega). DNA, re-suspended in alkaline gel
loading buﬀer (50mM NaOH, 1mM EDTA, 2.5% Ficoll
and 0.025% bromoCresol green), was loaded on a
denaturing gel as previously described (21). Following
electrophoresis, the gel was soaked in 0.25N HCl for
6–7min, rinsed and neutralised in 0.5N NaOH, 1.5M
NaCl for 30min, blotted onto a positively charged
membrane and hybridized according to standard proce-
dures with speciﬁc radiolabelled probes, generated using
the Ready-To-Go DNA Labelling beads (Amersham
Pharmacia Biotech). Probes P1 (for the detection of
cryptic loxP site 1) P2 and P3 (to detect cryptic loxP site 2)
were generated by PCR from the PAC111L11 clone,
using primers c-loxP1F 50-CTCAGACACTTTGGTGGG
TC-30 and c-loxP1R 50-GACTTTCAGTATGGCTGCCT
AAC-30 for probe 1 (P1); c-loxP2F 50-CAGGAGTTAG
AGACCAGC-30 and c-loxP2R 50-GCTATCTCGGCTC
ACTG-30 for probe 2 (P2) and c-loxP3F 50-GAAGGGCT
GAGGTTAGGCAG-30 and c-loxP3R 50-GAACACCTA
CTGAGCTTGAG-30 for probe 3 (P3).
RESULTS
Mouse genome-wide distribution of cryptic loxP sites
In order to assess the distribution and frequency of cryptic
loxP sites in the genome, a new bioinformatics tool
(FuzznucComparator) was developed to perform a mouse
genome-wide search (see materials and methods). Two
stringencies were applied. Primary cryptic loxP sites were
identiﬁed as sequences conforming to three patterns,
which together deﬁne a primary cryptic loxP site
(homology in the 13-bp palindromic sequences of the
loxP consensus sequence; conservation of base pairs in
the loxP site believed to be contact points for the Cre
enzyme and presence of the four bases (TATA) ﬂanking
the core sequence). Figure 1 shows the workﬂow for the
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search of cryptic loxP sites. FuzznucComparator also
deﬁned secondary cryptic loxP sites, using less stringent
criteria where the mismatch allowance for the three
patterns is increased arbitrarily by the operator. In our
hypothesis, some of these secondary sites have the
potential to bind Cre and mediate DNA damage, if they
are located near primary cryptic loxP sites.
The NCBI m34 mouse assembly (http://www.ncbi.nlm.
nih.gov/genome/seq/NCBIContigInfo.html) was split into
one-megabase regions and submitted to the Fuzznuc
and FuzznucComparator search for the three patterns
deﬁning a primary cryptic loxP site. The output of
the search is represented in Figure 2. The overall frequency
of primary cryptic loxP sites in the mouse genome is
1.2 per megabase. Some chromosomes show a more tightly
clustered distribution of cryptic loxP sites than others
(Figure 2, Chr 3, 13, 14, 15, 16, 18 and X). A few
chromosomes (Figure 2, Chr 1, 2, 4, 7, 16) present with hot
spots of cryptic loxP sites, generally 8 or 9 in a Mb DNA
window, but up to 17 in the case of chromosome 1.
Chromosome Y has no primary cryptic loxP sites.
About 10% of the spacer regions in primary cryptic
loxP sites are not unique, and occur more than once.
In silico identification of cryptic loxP inPAC/BACsequences
Three BAC and PAC clones (BACN10, ASBAC and
PAC111L11) were scanned for cryptic loxP sites
(in addition to the consensus loxP site in the backbone
Figure 2. Mouse genome-wide search for cryptic loxP sites. Each graph shows the distribution and the number of cryptic loxP sites in 1 Mb regions
along the 21 mouse chromosomes. The length of each graph is proportional to the corresponding chromosomal length. A megabase scale is present
at the bottom of each graph.
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of their respective vectors) to see whether their presence
caused instability in Cre-expressing host cells. Both
PAC111L11 and BACN10, which span the human
and mouse renin locus respectively, show the presence
of primary cryptic loxP sites that match all three patterns.
The search returned two potential cryptic loxP sequences
(c-loxP1 and c-loxP2) in PAC111L11 with 5 out of 8 bp
matching in the spacer region (62.5% identity) (Table 1).
A search for secondary cryptic loxP sites within 6 kb of
each primary site revealed one hit (sc-loxP), located 4.3 kb
upstream of c-loxP2 in PAC111L11. The sc-loxP has
twelve mismatches to the consensus loxP in the 13-bp
palindromic arms, 12 out of 18 conserved Cre contact
points and 3 mismatches in the TATA sequences ﬂanking
the spacer region. When aligned with the complementary
strand of the c-loxP2 site, 4 out of 8 bp match in the
spacer region.
BACN10 is predicted to contain four primary cryptic
loxP sites. Two of these are identical at 6 out of 8 bp in
the spacer region and the other two match at 5; both pairs
of sites show conservation in the four bases ﬂanking
the spacer region (Table 1). A search for secondary cryptic
loxP sites in the regions surrounding the primary
sites returned one hit with the same characteristics
outlined for the sc-loxP site in PAC111L11.
ASBAC contains 5 sequences that match the ﬁrst
two criteria for primary cryptic loxP sites but, when
considered in pairs, none show conservation in the four
bases ﬂanking the core region (Table 1). Since not all
three criteria for cryptic loxP deﬁnition are satisﬁed, these
sites are not predicted to be functional.
Differential growth of PAC/BAC-transformed EL350
E. coli strain compared to DY380 and EL250
To test the hypothesis that cryptic loxP sites mediate DNA
damage in E. coli strains expressing Cre recombinase,
PAC111L11 (depicted in Figure 3) was transformed
into DY380 (expressing neither Cre nor Flp), EL250
(expressing Flp) and EL350 (expressing Cre) E. coli (3).
Transformed cells were grown in the presence of arabinose
(to induce the AraC-PBAD promoter) or glucose (to ensure
catabolite repression of the promoter) (22–24). Whilst
the growth of PAC111L11-transformed DY380 and
EL250 cells was similar on plates containing glucose or
arabinose (Figure 4B and C), the growth of PAC111L11-
transformed EL350 cells diﬀered on arabinose, with
a similar number of colonies of much smaller size
(Figure 4A). Statistically signiﬁcant reduced colony
diameter is observed on arabinose plates when comparing
PAC111L1-transformed EL350 (colony diameter
0.51 0.02mm) cells to PAC111L11-transformed DY380
(colony diameter 1.69 0.02mm on arabinose, p50.001)
or EL250 (colony diameter 1.44  0.02mm on arabinose,
Table 1. Number of primary cryptic loxP sites in three BAC/PAC molecules and their characteristics
PAC/BAC
name
Putative primary
cryptic loxP sites
(search pattern1 and 2)
Pairs of primary c-loxP
sites with 6/8 matches
in the spacer region
Pairs of primary c-loxP
sites with 5/8 matches
in the spacer region
Pairs that have conservation
in the 4 bases ﬂanking the
spacer region
PAC111L11(H) 2 0 1 1
ASBAC (M) 5 0 1 0
BACN10 (M) 4 1 1 2
B
3′
TAAAATTTTTAATCTTCTTTTATTATTTCTTTTGsc-loxP
TATA TGGATGAATTATACATAATA AAAAAGTATAc-loxP site 2
TATA TATATATATTGTGTATAAAAATGACATATAc-loxP site 1
TATA CGAAGTTATGCATACATATAACTTCGTATAloxP Consensus
Palindrome BSpacerPalindrome A
A
Ren
90 kb 35 kb
sc-loxP c-loxP2
70 kb
5′
c-loxP1
Figure 3. (A) Positions of the cryptic loxP sites on the PAC111L11 insert. (B) Sequence comparison between the loxP consensus site and PAC111L11
cryptic loxP sites (primary c-loxP and secondary sc-loxP). Underlined nucleotides — Cre contact points on loxP consensus sequence;
bold — conserved nucleotides.
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p50.01) cells. In addition, the EL350-PAC111L11 colo-
nies formed in the presence of glucose were appreciably
smaller than those formed by DY380 or EL250 transfor-
mants. The eﬀect of glucose on PAC111L11-transformed
EL350 colony size is concentration-dependent with 1%
glucose resulting in the largest colonies (Figure 5).
Un-transformed DY380 and EL350 cells grow with the
same eﬃciency in 0.2% arabinose-containing agar, despite
the presence of one primary cryptic loxP site in the E. coli
bacterial genome (Figure 5, inset).
EL350 cells transformed with BACN10 also gave rise to
very small colonies that failed to grow or had delayed
growth on arabinose (data not shown), whereas EL350
cells transformed with ASBAC showed no diﬀerence in
growth rate.
In vivo assay for Cre activity in EL350
Low levels of expression from the PBAD promoter
can occur in the absence of the inducer arabinose
if the expression at maximum induction is very high.
Leaky Cre expression from the AraC-PBAD promoter
has been described for multi-copy plasmids (25). However,
in EL350 cells the AraC-PBAD-Cre gene is present in
a single copy. To test if Cre was produced from the
un-induced AraC-PBAD promoter in EL350, a functional
test was performed, using a plasmid vector (pROSA26/
Tet) encoding a tetracycline resistance gene between two
loxP consensus sequences (Figure 6A). The plasmid
pROSA26/Tet also confers ampicillin resistance to the
host. If recombination occurs between the loxP sequences,
the Tet resistance gene is excised and the E. coli strain can
only grow under Amp selection. This was the case when
Cre expression in EL350 cells was induced with arabinose.
Two cell dilutions (104 and 106) were plated on LB agar
plates containing either 50 mg/ml ampicillin or 25 mg/ml
tetracycline or both. Although many colonies were
obtained on ampicillin, no colonies were observed on
Amp/Tet or Tet plates (Figure 6B), even after 24 h.
Following transformation with pROSA26/Tet, Tet resis-
tant colonies were obtained in the absence of arabinose
(when the AraC-PBAD promoter is not induced in EL350
cells), however, the number of colonies was reduced
Figure 4. Growth of PAC111L11-transformed EL350 (A), DY380
(B) and EL250 (C) cells on LB agar supplemented with either 0.2%
glucose or 0.2% arabinose. Arrows indicate very small and barely
detectable colonies formed on arabinose-containing agar by EL350/
PAC111L11.
Figure 5. Growth of PAC111L11-transformed EL350 on LB agar
supplemented with increasing concentrations of glucose. Inset:
Un-transformed EL350 and DY380 on agar with 0.2% arabinose.
Figure 6. (A) pROSA26/Tet plasmid map. (B) Summary of the
transformation of pROSA26/Tet plasmid into EL350. (C) PCR analysis
of pROSA26/Tet transformed EL350 and DY380 under arabinose-
induced and un-induced conditions using T3 and T7 primers. M1: 1 Kb
Marker (New England Biolabs). M2: pBluescriptII SKþ plasmid
digested with Sau3AI. The 1.5Kb band indicates the presence of the
Tet gene; the 0.2Kb band is generated after Cre/loxP-mediated excision
of the Tet gene.
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approximately twenty-fold (Figure 6B). These data show
that about 95% of the colonies that are able to grow on
an Amp/Tet plate have lost the tetracycline gene and are
no longer able to grow under tetracycline selection
(p50.01). In order to verify if all the plasmid molecules
inside a single E. coli colony have undergone site-speciﬁc
recombination or a few of them retain the tetracycline
resistance gene, a PCR assay was performed on colonies
using primer T3 and T7 (Figure 6C). A mixed plasmid
population (excised and non-excised) is recovered from
un-induced EL350. This is shown by the presence of two
DNA fragments, one of 1.5Kb (Tet retaining plasmids)
and one of 0.2Kb (Tet excised plasmids). After induction
of EL350 with arabinose, the tetracycline resistance gene
was found to be 100% excised. Plasmids that grow
into DY380 do not show any sign of site-speciﬁc
recombination and maintain the tetracycline resistance
gene (Figure 6C, right panel).
Analysis of nicks in PAC111L11 DNA after incubation
with Cre
The ability of Cre recombinase to introduce single or
double-strand nicks at cryptic loxP sites was tested by
incubation with PAC111L11 DNA. DNA fragments
produced by the action of Cre were detected by
Southern blot following either HindIII or EcoRVV
restriction digest for the analysis of c-loxP1 nicks or c-
loxP2 nicks, respectively using a c-loxP1 speciﬁc probe
(P1) or c-loxP2 speciﬁc probes (P2 and P3; Figure 7).
PAC111L11 DNA showed no evidence of nicking or
cleavage at c-loxP1 following overnight incubation with
Cre recombinase (Figure 7C). Only one band of 3.5 kb,
corresponding to the intact DNA, was detected by probe
P1. In contrast, hybridization of probes P2 and P3 to
EcoRVV-digested PAC111L11 DNA detected fragments
consistent with cleavage at both c-loxP2 and sc-loxP sites
(Figure 7D and E). In the absence of Cre, the expected
Figure 7. In vitro analysis of the presence of nicks in PAC111L11 insert. (A) Schematic representation of expected fragment size for DNA nicked at
cryptic loxP1 site. The arrow indicates the location of the c-loxP1 site on the HindIII fragment. P1: probe 1. (B) Schematic representation of
predicted fragment sizes for DNA nicked at the c-loxP2 and secondary sc-loxP sites on the EcoRVV fragment. Arrows indicate the location of the
c-loxP2 and sc-loxP sites, P2 — probe 2, and P3 — probe 3. (C) Southern analysis of PAC111L11 DNA, following overnight incubation with Cre
recombinase, digested with HindIII and hybridized to probe P1 to detect nicks produced at the c-loxP1 site. M:1 kb DNA ladder (NEB) Plus and
minus signs on each lane refer to the presence or absence of Cre recombinase and its relative abundance. (D) and (E) Southern analysis of
PAC111L11 DNA, following overnight incubation with Cre recombinase, digested with EcoRVV and hybridized with probe P2 (D) and P3 (E) to
detect nicks produced by cryptic loxP site 2 and/or sc-loxP. M:1 kb DNA ladder (NEB) Plus and minus signs on each lane refer to the presence or
absence of Cre recombinase and its relative concentration.
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6.6 kb fragment produced by EcoRVV digestion of intact
PAC111L11 DNA was detected. At the higher concentra-
tion of Cre, additional fragments of 4.3 kb (with probe P2,
Figure 7D) and 0.9 kb (with probe P3, Figure 7E) were
detected.
These results suggest that the primary (c-loxP2) and the
secondary (sc-loxP) c-loxP sites that map in the
PAC111L11 insert are able to bind Cre recombinase
enzyme and start a recombination event, which is
non-productive and results in damage to the PAC
DNA molecule.
The absence of the nicked 2.9 kb at the c-loxP1 site and
5.7 kb at the c-loxP2 site suggests that these cryptic loxP
site are not getting paired and defectively recombined with
the proper consensus loxP site that is located in the
backbone of the PAC sequence.
DISCUSSION
Although little evidence has been reported, certain BAC/
PAC inserts are diﬃcult to propagate in Cre-containing
E. coli strains. It is possible this could be due to low
levels of Cre promoting single strand DNA breaks or
recombination through cryptic loxP sites present in the
inserts. Computational analysis of the whole mouse
genome has revealed an average of 1.2 primary cryptic
loxP sites per Mb DNA, with few hotspots present
(chromosome y has none). The new bioinformatic tool,
FuzznucComparator has been made available through
a Distributed Annotation System (DAS) resource to
enable dynamic access to the data using http requests
(i.e. a URL), with the response being returned as XML.
This resource is implemented using a Dazzle [DAZZLE]
server backed by an LDAS database and can be accessed
at: http://wilkie226.dmed.ed.ac.uk:8080/das. Access via
the DAS protocol also allows these annotations to be
viewed as a track within Ensembl (Ensembl help, http://
www.ensembl.org/Homo_sapiens/helpview?se¼1;kw¼das
confview, documents how to achieve this).
We have tested the power of the programme to predict
functional cryptic loxP sites in the genomic insert of BAC
and PAC sequences, which could potentially aﬀect their
growth in Cre recombinase expressing E. coli strains. We
have identiﬁed primary and secondary cryptic loxP sites
in the genomic insert of three BAC/PAC clones and
shown that these are substrates for Cre recombinase in
vitro. Furthermore, following transformation into
EL350 cells, they demonstrate a dramatically reduced
growth rate in the presence of arabinose, compared to
DY380 and EL250. The poor growth is ameliorated
by glucose suggesting a Cre-mediated eﬀect on bacterial
growth. We suggest that, since Cre recombinase is leaky,
EL350 has a growth defect when transformed
with PAC111L11.
Despite the higher conservation level of c-loxP1 and
c-loxP2, our data shows that c-loxP2 and sc-loxP are
involved in the single-strand nicking of PAC111L11,
incubated in vitro with Cre recombinase. c-loxP2 and
sc-loxP are located relatively close to each other, whereas
c-loxP1 lies 70 kb away from c-loxP2. The interaction of
Cre recombinase with cryptic loxP sites is likely to be
weaker than with genuine loxP sites. However, proximity
of two cryptic loxP sites may serve to increase the local
concentration of Cre recombinase, increasing the
likelihood of DNA nicking at one or both sites.
All three BAC/PAC molecules we have analysed
contain a loxP consensus sequence in their respective
vector backbones. However, we consider it unlikely that
they mediate nicking for the following reasons: (1) they
occur in most if not all BAC/PAC vectors and clearly
DNA nicking and poor growth is not a problem with all
BAC/PACs. (2) ASBAC also encode putative cryptic loxP
sites, however, their presence did not result in slower
growth in EL350 cells than EL250 or DY380 cells. We
cannot exclude that in other molecules DNA damage
might occur if the conditions (homology in the spacer
region and location of the c-loxP site close to the end of
the insert, and thus proximal to the genuine loxP site) are
favourable. These data provide a functional deﬁnition of
active cryptic loxP sites; more relaxed mismatches
allowance in comparison to the criteria previously set
(12) shows that a high degree of deviation from the loxP
consensus sequence is still tolerated by Cre recombinase.
The demonstration that Cre recombinase expression is
leaky in this strain supports the hypothesis that the
damaged PAC DNA fails to replicate, depriving the E. coli
daughter cells of the selectable marker. These ﬁndings
are in accordance with data in the literature that show
that mammalian genomes contain active recombinase
recognition sites (12) and that growth inhibition and
DNA damage can be induced by the expression of
Cre recombinase in mammalian cells, E. coli and yeast
(14,26–28). The leakiness of Cre recombinase in EL350
cells is not surprising. Studies have demonstrated that
PBAD promoters are very eﬃcient, but the levels of
repression are not always zero, because they are relative
to the levels of expression at maximum induction (25).
During cleavage, Cre becomes covalently attached to
the DNA through a 30-phosphate. This type of covalent
protein-DNA linkage is very similar to that observed with
DNA topoisomerases (11,29–31). In the presence of
cryptic loxP sites or mutant loxP sites (11), Cre protein
attempts to carry out recombination, but the reaction is
abortive. If the reaction progresses to the stage where
nicks are introduced into the DNA, then a damaged DNA
molecule is produced, which is covalently linked to a
protein making it very diﬃcult to repair by the cell repair
machinery (32).
Many lines of transgenic mice have been generated that
express Cre recombinase, but there are few reports of
adverse eﬀects of this protein in vivo. The potential for
DNA damage is demonstrated by the infertility of
transgenic mice expressing Cre in spermatids, due to
illegitimate Cre-dependent chromosome rearrangements
(13). It is possible that somatic mutations remain
undetected, due to the high tolerance of mammals for
somatic cell death and, in light of this study, a more
detailed analysis of the phenotype of transgenic animals
bearing the Cre recombinase gene may be informative.
Finally, these results suggest that the presence of cryptic
loxP sites in BAC/PAC inserts can aﬀect the eﬃciency of
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recombineering techniques if the host cells express Cre
recombinase even in a leaky way. This problem is
BAC/PAC dependent and does not diminish the useful-
ness of recombineering techniques. Nevertheless, these
data propose and describe a mechanism, which explains
why recombineering experiments sometimes don’t give the
expected results and provide a bioinformatic tool, which
can alert and guide in the planning process. The
use of FuzznacComparator to identify cryptic loxP sites
in BAC/PAC inserts may be helpful in determining which
BACs may prove to be most manipulatable with the
Cre/loxP system.
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